Rivaroxaban Precision Dosing Strategy for Real‐World Atrial Fibrillation Patients
Rivaroxaban is a direct‐acting oral anticoagulant approved to prevent strokes in patients with atrial fibrillation. Dosage recommendations are approved for all adult patients to receive either 15 mg or 20 mg once daily depending upon renal function. There are a number of reasons to believe rivaroxab...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Libro |
| Publicado: |
Wiley,
2020-07-01T00:00:00Z.
|
| Materias: | |
| Acceso en línea: | Connect to this object online. |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|